Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Spectrum Pharmaceuticals Q3 EPS $(0.12) Beats $(0.15) Estimate

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share
byBenzinga Newsdesk
November 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: XPO Logistics Q3 Earnings

By Benzinga Insights
October 31, 6:26 AM
XPO Logistics (NYSE:XPO) reported its Q3 earnings results on Monday, October 31, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings XPO Logistics beat estimated earnings by 8.21%, reporting an EPS of $1.45 versus an estimate of $1.34.

XPO